APA

Ahn C. H., Han K. A., Yu J. M., Nam J. Y., Ahn K. J., Oh T. K., Lee H. W., Lee D. H., Kim J., Chung C. H., Park T. S., Kim B. J., Park S. W., Park H. K., Lee K. J., Kim S., Park J. H., Ko K. P., Kim C. H., Lee H., Jang H. C. & Park K. S. (20171010). Efficacy and safety of gemigliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24-week, multicentre, randomized, double-blind, placebo-controlled study (TROICA study). : Diabetes, obesity & metabolism.

Chicago

Ahn Chang Ho, Han Kyung Ah, Yu Jae Myung, Nam Joo Young, Ahn Kyu Jeung, Oh Tae Keun, Lee Hyoung Woo, Lee Dae Ho, Kim Jaetaek, Chung Choon Hee, Park Tae Sun, Kim Byung Joon, Park Seok Won, Park Hyeong Kyu, Lee Kwang Jae, Kim Sang-Wook, Park Jeong Hyun, Ko Kwan Pyo, Kim Chong Hwa, Lee Hyunjin, Jang Hak Chul and Park Kyong Soo. 20171010. Efficacy and safety of gemigliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24-week, multicentre, randomized, double-blind, placebo-controlled study (TROICA study). : Diabetes, obesity & metabolism.

Harvard

Ahn C. H., Han K. A., Yu J. M., Nam J. Y., Ahn K. J., Oh T. K., Lee H. W., Lee D. H., Kim J., Chung C. H., Park T. S., Kim B. J., Park S. W., Park H. K., Lee K. J., Kim S., Park J. H., Ko K. P., Kim C. H., Lee H., Jang H. C. and Park K. S. (20171010). Efficacy and safety of gemigliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24-week, multicentre, randomized, double-blind, placebo-controlled study (TROICA study). : Diabetes, obesity & metabolism.

MLA

Ahn Chang Ho, Han Kyung Ah, Yu Jae Myung, Nam Joo Young, Ahn Kyu Jeung, Oh Tae Keun, Lee Hyoung Woo, Lee Dae Ho, Kim Jaetaek, Chung Choon Hee, Park Tae Sun, Kim Byung Joon, Park Seok Won, Park Hyeong Kyu, Lee Kwang Jae, Kim Sang-Wook, Park Jeong Hyun, Ko Kwan Pyo, Kim Chong Hwa, Lee Hyunjin, Jang Hak Chul and Park Kyong Soo. Efficacy and safety of gemigliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24-week, multicentre, randomized, double-blind, placebo-controlled study (TROICA study). : Diabetes, obesity & metabolism. 20171010.